IO Frontiers World 2019

Speakers

Loading
David Poon, Ph.D.

David Poon, Ph.D.

Executive Director, External R&D and Alliances, Zymeworks

David is the Executive Director of External R&D and Alliances at Zymeworks and he is leading the business development and alliance management group responsible for product commercialization and strategic in and out-licensing, search and evaluation, competitive intelligence, and alliance management. During his tenure at Zymeworks David led a number deals with multinationals including Johnson & Johnson Innovations, Celgene, Eli Lilly, and Daiichi Sankyo with total deal size in excess of $5B. David also established key partnerships with academic institutions, government organizations (e.g. NRC), and other contract research organizations. David was also involved in key scientific contributions relating to Zymeworks’ Azymetric™ and AlbuCORE™ bispecific/multispecific platforms. David received his Ph.D. in Chemistry from the University of British Columbia.

Sessions
  • "Great venue to solidify and harmonize on the current challenges facing this sector - in real time. The caliber of the speakers and session contents was premier. “
    Dolores Baksh
    Innovation Leader, GE Healthcare
  • “A great event to learn about the hurdles that are needed to be overcome to get through the clinic.”
    Devin Bridgen
    Scientist, strategic partnerships, SQZ Biotech
  • "It was a great opportunity to share current data and thinking about the development of therapeutics directed at modulating the immune response to cancer."
    Lance Leopold
    Vice President, Head of Oncology Development, Incyte Corporation
  • "Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field."
    Dr James Trager
    Vice President, Research & Product Development, Dendreon
  • “In the rapidly moving Advanced Therapy market, Phacilitate remains one of the premier events.”
    David James
    CEO, Scinogy